Tesetaxel as First-line Therapy for Metastatic Breast Cancer

Clinical trial NCT01221870 · UNKNOWN

Trial details

NCT number: NCT01221870
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2010-11-01
Primary completion: 2012-10-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.